Writing here as a board member for the Multidisciplinary Association of Psychedelic Studies (MAPS), it’s been a crazy few months. I have no doubt that the Food & Drug Administration will eventually approve MDMA-assisted therapy for PTSD after more clinical research hoops are jumped through, but the media and cultural hysteria that preceded their disappointing decision to delay approval was hard to watch...Continue Reading